ATRC
AtriCure Inc
60.80$
+1.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +2.3% | -3.6% | +1.0% | +3.0% | -0.9% | -2.9% | +2.9% | +4.4% | +2.9% | -1.6% | +5.1% | |
| – | +5.4% | -7.9% | +3.1% | +6.5% | -0.5% | -6.1% | +7.9% | +11.0% | +7.1% | -2.7% | +10.1% | |
| – | +4.6% | -22.9% | +63.2% | +22.9% | -5.8% | -18.6% | +17.9% | +25.5% | +13.2% | -12.7% | +14.8% | |
| – | +3.2% | -22.8% | +7.6% | +14.3% | -5.8% | -18.6% | +17.9% | +25.5% | +13.2% | -12.7% | +14.8% | |
| – | +1.9% | +5.4% | +0.5% | -1.2% | +9.9% | +4.9% | +4.2% | -4.6% | +5.8% | +7.0% | +12.2% | |
| – | +9.7% | +6.0% | +2.4% | +3.9% | -1.6% | -0.6% | +1.9% | +3.4% | -0.6% | +3.4% | +3.4% | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -2.6% | -2.9% | -3.0% | -3.1% | -3.2% | -3.7% | -3.9% | -4.0% | -4.2% | -5.0% | +509.2% | |
| – | +7.5% | -8.4% | -0.1% | +11.0% | -1.1% | -7.6% | +5.4% | +10.1% | +2.1% | -6.1% | +5.2% | |
| – | -9.7% | -17.9% | 0.0% | +21.6% | -1.4% | -16.6% | +12.4% | +13.1% | +4.7% | -10.2% | +11.9% | |
| – | -87.8% | +0.4% | 0.0% | +6.8% | +3.3% | +1.2% | +2.4% | +3.1% | +4.1% | +0.3% | – | |
| – | +11.5% | +6.0% | -8.0% | +19.0% | -21.1% | +0.6% | +2.0% | -0.8% | +207.8% | -61.0% | +157.7% | |
| – | +43.7% | +2.1% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -1.4% | +0.0% | |
| – | +0.7% | -2.1% | +1.3% | +0.6% | -0.9% | -1.4% | +2.2% | +2.6% | +3.2% | 0.0% | +5.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.1% | +0.6% | +0.4% | +0.4% | +0.0% | +0.6% | +0.3% | +0.3% | +2.5% | +0.4% | +0.1% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.